Pierre Caloz
Chief Operating Officer at UNIQURE N.V.
Net worth: 616 944 $ as of 2024-03-30
Profile
Pierre Caloz is currently the Chief Operating Officer at uniQure NV since 2021.
Prior to this, he worked as the SVP, GM-European Union & Asia Pacific Operations at CSL Behring NV.
Caloz completed his undergraduate degree from the University of Geneva in 1996, followed by a graduate degree from the Swiss Federal Institute of Technology in 1997.
He also holds an MBA from Ashridge Business School, which he completed in 2010.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
UNIQURE N.V.
0.25% | 2024-02-29 | 118,643 ( 0.25% ) | 616 944 $ | 2024-03-30 |
Pierre Caloz active positions
| Companies | Position | Start |
|---|---|---|
| UNIQURE N.V. | Chief Operating Officer | 2021-05-16 |
Former positions of Pierre Caloz
| Companies | Position | End |
|---|---|---|
CSL Behring NV
 CSL Behring NV BiotechnologyHealth Technology CSL Behring NV engages in the research and development of biotherapies for the treatment of rare and severe illnesses. It offers hematology, immunology, pneumology and specific medicine. The company was founded on February 15, 1995 and is headquartered in Mechelen, Belgium. | Corporate Officer/Principal | - |
Training of Pierre Caloz
| University of Geneva | Undergraduate Degree |
| Swiss Federal Institute of Technology | Graduate Degree |
| Ashridge Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| UNIQURE N.V. | Health Technology |
| Private companies | 1 |
|---|---|
CSL Behring NV
CSL Behring NV BiotechnologyHealth Technology CSL Behring NV engages in the research and development of biotherapies for the treatment of rare and severe illnesses. It offers hematology, immunology, pneumology and specific medicine. The company was founded on February 15, 1995 and is headquartered in Mechelen, Belgium. | Health Technology |
- Stock Market
- Insiders
- Pierre Caloz
